Impact of lopinavir-ritonavir exposure in HIV-1 infected children and adolescents in Madrid, Spain during 2000-2014

BACKGROUND: The most-used protease-inhibitor in children is Lopinavir-ritonavir (LPV/r), which provides durable suppression of viral load and increases CD4+T-counts. This study describes the virological outcome of the HIV-1-infected paediatric population exposed to LPV/r during 15 years in Spain. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas Sánchez, Patricia, Prieto, Luis, Jiménez De Ory, Santiago, Fernández Cooke, Elisa, Navarro, Maria Luisa, Ramos, José Tomas, Holguín, África
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369685/
https://www.ncbi.nlm.nih.gov/pubmed/28350802
http://dx.doi.org/10.1371/journal.pone.0173168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369685/
https://www.ncbi.nlm.nih.gov/pubmed/28350802
http://dx.doi.org/10.1371/journal.pone.0173168

Ejemplares similares